The outbreak of COVID-19: An overview
By Yi-Chi Wu, Ching-Sung Chen, Y. Chan. Journal of the Chinese Medical Association, 2020
869 citations recorded by the source corpus.
In late December 2019, a previous unidentified coronavirus, currently named as the 2019 novel coronavirus#, emerged from Wuhan, China, and resulted in a formidable outbreak in many cities in China and expanded globally, including Thailand, Republic of Korea, Japan, United States, Philippines, Viet Nam, and our country (as of 2/6/2020 at least 25 countries). The disease is officially named as Coronavirus Disease-2019 (COVID-19, by WHO on February 11, 2020). It is also named as Severe Pneumonia with Novel Pathogens on January 15, 2019 by the Taiwan CDC, the Ministry of Health and is a notifiable communicable disease of the fifth category. COVID-19 is a potential zoonotic disease with low to moderate (estimated 2%–5%) mortality rate. Person-to-person transmission may occur through droplet or contact transmission and if there is a lack of stringent infection control or if no proper personal protective equipment available, it may jeopardize the first-line healthcare workers. Currently, there is no definite treatment for COVID-19 although some drugs are under investigation. To promptly identify patients and prevent further spreading, physicians should be aware of the travel or contact history of the patient with compatible symptoms.
Subfields: Infectious Diseases, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/4e7b16326d0166ece4ebdf4c5c1d70173d70f381
Citations in the corpus
- Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study (2020, neutral): “2019-novel coronaviruses belong to the β species of coronaviruses, which mainly transmitted through respiratory droplets and close contact, and it can be found in human respiratory epithelial cells in about 96 h, which firstly attacks the lungs and induces serous fluid, fibrin exudates, and hyaline ”